BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15955561)

  • 1. Rapamycin and FK506 reduce skeletal muscle voltage sensor expression and function.
    Avila G; Dirksen RT
    Cell Calcium; 2005 Jul; 38(1):35-44. PubMed ID: 15955561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FK506 on [Ca2+]i differ in mouse and rabbit ventricular myocytes.
    Su Z; Sugishita K; Li F; Ritter M; Barry WH
    J Pharmacol Exp Ther; 2003 Jan; 304(1):334-41. PubMed ID: 12490609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of sarcoplasmic reticulum (SR) Ca2+ release by FK506 induces defective excitation-contraction coupling only when SR Ca2+ recycling is disturbed.
    Yoshihara S; Satoh H; Saotome M; Katoh H; Terada H; Watanabe H; Hayashi H
    Can J Physiol Pharmacol; 2005 Apr; 83(4):357-66. PubMed ID: 15877110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitation-contraction coupling in cardiac muscle revisited.
    Lewartowski B
    J Physiol Pharmacol; 2000 Sep; 51(3):371-86. PubMed ID: 11016858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction.
    Long C; Cook LG; Wu GY; Mitchell BM
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1580-6. PubMed ID: 17478757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes.
    Avila G; Lee EH; Perez CF; Allen PD; Dirksen RT
    J Biol Chem; 2003 Jun; 278(25):22600-8. PubMed ID: 12704193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible role of the junctional face protein JP-45 in modulating Ca2+ release in skeletal muscle.
    Gouadon E; Schuhmeier RP; Ursu D; Anderson AA; Treves S; Zorzato F; Lehmann-Horn F; Melzer W
    J Physiol; 2006 Apr; 572(Pt 1):269-80. PubMed ID: 16423849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 (tacrolimus) increases halothane-induced Ca2+ release from skeletal muscle sarcoplasmic reticulum.
    Chini EN; Walker H
    Anesthesiology; 2000 May; 92(5):1361-5. PubMed ID: 10781282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered excitation-contraction coupling with skeletal muscle specific FKBP12 deficiency.
    Tang W; Ingalls CP; Durham WJ; Snider J; Reid MB; Wu G; Matzuk MM; Hamilton SL
    FASEB J; 2004 Oct; 18(13):1597-9. PubMed ID: 15289441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage dependence of cardiac excitation-contraction coupling: unitary Ca2+ current amplitude and open channel probability.
    Altamirano J; Bers DM
    Circ Res; 2007 Sep; 101(6):590-7. PubMed ID: 17641229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergence in the behaviour of the dihydropyridine receptor in muscle.
    Lüttgau HC
    J Physiol; 2000 Aug; 526 Pt 3():469. PubMed ID: 10921999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of FK506 and rapamycin on excitation-contraction coupling in skeletal muscle fibres of the rat.
    Lamb GD; Stephenson DG
    J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):569-76. PubMed ID: 8842013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation-dependent redistribution of charge movement between unavailable and available states.
    Stroffekova K; Heiny JA
    Gen Physiol Biophys; 1997 Mar; 16(1):79-89. PubMed ID: 9290945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the sarcoplasmic reticulum in regulating the activity-dependent expression of the glycogen phosphorylase gene in contractile skeletal muscle cells.
    Vali S; Carlsen R; Pessah I; Gorin F
    J Cell Physiol; 2000 Nov; 185(2):184-99. PubMed ID: 11025440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered inactivation of Ca2+ current and Ca2+ release in mouse muscle fibers deficient in the DHP receptor gamma1 subunit.
    Ursu D; Schuhmeier RP; Freichel M; Flockerzi V; Melzer W
    J Gen Physiol; 2004 Nov; 124(5):605-18. PubMed ID: 15504904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
    Avila G; Dirksen RT
    J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide fragments of the dihydropyridine receptor can modulate cardiac ryanodine receptor channel activity and sarcoplasmic reticulum Ca2+ release.
    Dulhunty AF; Curtis SM; Cengia L; Sakowska M; Casarotto MG
    Biochem J; 2004 Apr; 379(Pt 1):161-72. PubMed ID: 14678014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular architecture of the sarcoplasmic reticulum and its role in the ECC].
    Rigoard P; Buffenoir K; Wager M; Bauche S; Giot JP; Lapierre F
    Neurochirurgie; 2009 Mar; 55 Suppl 1():S83-91. PubMed ID: 19233437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FKBP12.6 in hypoxia- and norepinephrine-induced Ca2+ release and contraction in pulmonary artery myocytes.
    Zheng YM; Mei QB; Wang QS; Abdullaev I; Lai FA; Xin HB; Kotlikoff MI; Wang YX
    Cell Calcium; 2004 Apr; 35(4):345-55. PubMed ID: 15036951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle.
    Ahern GP; Junankar PR; Pace SM; Curtis S; Mould JA; Dulhunty AF
    J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):313-26. PubMed ID: 9852316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.